Opinion Richie Etwaru, Human Data Ethicist, and CEO of Hu-manity.co issues a warning to the pharmaceutical industry: Build trust with the consumer and change the narrative of public perception, before it is too late.   There is a ¼ trillion-dollar torpedo pointing at Pharma’s biggest weakness, the pharma industry never had…

Opinion Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare disease patient himself, he is responsible for bringing“International Rare Disease Day” to China. Consequently, rare diseases now have much more visibility in the country. As an expert on the subject, Kevin breaks…

Opinion Drug development in rare diseases is currently in a very exciting time. While much of the focus is on the scientific advances,  access to rare disease patients and well-designed clinical trials are also essential to evaluating new therapeutics. In this article, PJ Brooks, Program Director at the Office of Rare…

China What do executive recruitment firms look for when hiring country managers for multinational pharma companies in some of the world’s most challenging markets? Eric Bouteiller and Simon Wan of  Cornerstone International Group outline what they look for in potential candidates for country manager positions in China.   The Ideal China…

MENA The Middle East and North Africa (MENA) region’s pharmaceutical market is projected to reach a value of around USD 60 billion by 2025 according to reporting from TradeArabia. The most impressive growth is coming from the UAE, but North African giants Egypt and Algeria are also significant contributors.   Factors…

India Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s ambitious healthcare insurance scheme, “Modicare” and delves into some of its critical challenges and associated opportunities for private players.   In theory, India’s states will be able to fine tune Modicare’s implementation to meet their…

Trends As we move further into 2019, Emmanuel Fombu, MD, MBA: Author and Global Commercial Strategy and Digital Innovation Leader at Johnson and Johnson, reflects on what to expect from the rest of the year and beyond in the pharmaceutical landscape. The battle for market share in the future will likely…

Digitalization In an increasingly digitalised world, pharma companies are having to reconsider their communication strategies. Some, such as Swiss giant Roche, are turning to online webinars to better engage with healthcare practitioners (HCPs) across the globe.   Today’s doctors are time-crunched and digital-savvy, and they want targeted and relevant communication solutions…

Korea South Korean heavyweight Daewoong Pharmaceutical saw record sales in 2018, but did see a decrease in its EBITDA figures. To ensure its future profitability, the company has decided to invest heavily in the research of development of new drugs, with a new 100 billion won facility planned.   Daewoong Pharmaceutical’s…

Diversity Annually, PharmaBoardroom conducts hundreds of interviews with global CEO’s, country managers and industry leaders in the pharma industry. While we have crossed paths with many inspiring females in these positions, out of the top 50 pharma companies, only 3 are headed by women. That is a mere 6% — this…

Opinion On International Women’s Day 2019, David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made to close the gender investment gap, touching on key trends and biases in venture capital funding and outlining why investing in women matters.   When women business owners pitch their…

China China is planning to establish a new national medical ethics committee in the wake of the “CRISPR babies” scandal.   The committee will not be limited to overseeing gene editing alone, but also cover cloning, cell therapy, xenotransplantation, mitochondrial replacement, and nanotechnology The new body, according to reports, will oversee…